a - has every right to these patents in question. But...

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
Oral Argument 3: Myriad Genetics Breast Cancer Gene Patent Case (CA Fed Cir. 7.29.11) Being on the side of Myriad Genetics, at first I was unable to persuade myself that Myriad had any merit in its claims. Just the mention of breast cancer and gene patents immediately locks in an image of a greedy corporation making money off of women dying of breast cancer. And that image stayed there for a while. Not until after reading every word of both briefs and starting to craft our argument did I really appreciate Myriad’s side. After the presentation, though not 100% convinced, I am more on Myriad’s side. Legally, I think Myriad
Background image of page 1
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: has every right to these patents in question. But seeing as how Supreme Court cases can overturn and adjust laws, it probably is important to consider ethics. Ethically it comes down to whether more good is generated from freedom of this particular application or from the monetary backing of Pharmaceutical companies. I think now Im more convinced that upholding this patent helps research and identification more than it hurts. All I know is I do not envy the work Myriads lawyers have before them if the Supreme Court takes this case....
View Full Document

This note was uploaded on 01/31/2012 for the course LEGL 2700H taught by Professor Pagnattaro during the Fall '11 term at University of Georgia Athens.

Ask a homework question - tutors are online